Exactus, Inc. EXDI OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

17/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Exactus, Inc. (EXDI) reported total assets of $-2.82M and total liabilities of $4.9M for fiscal year 2020, resulting in total equity of $-3.02M.

The company held $25.14K in cash and short-term investments. Total debt stood at $130.34K, with net debt of $105.21K. The Debt-to-Equity (D/E) ratio was -0.04 (conservative).

Current ratio is 0.01, which may signal tight short-term liquidity. Interest coverage is -10.5x (weak).

Criteria supported by this page:

HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (15/100) — Total assets $-2.82M and equity $-3.02M support the company's competitive scale

Overall SharesGrow Score: 16/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

17/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

15/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Exactus, Inc. Balance Sheet History

Metric	FY2020	FY2019	FY2018	FY2017
Total Assets	$-2.82M	$9.8M	$14.29K	$172.67K
Total Liabilities	$4.9M	$6.12M	$3.44M	$2.39M
Total Debt	$130.34K	$673.53K	$643.19K	$105.8K
Cash & Investments	$25.14K	$18.41K	$1.96K	$161.22K
Total Stockholders Equity	$-3.02M	$4.22M	$-3.42M	$-2.22M